Element Biosciences raised over $277M in Series D funding led by Wellington Management with participation from Samsung Electronics, Fidelity, Foresite Capital, and others to support the commercialization of AVITI™ and the upcoming launch of AVITI24™.
Amount Raised
$277 Million
Round Type
Series D
San DiegoBiotechnologyHealth CareGeneticsLife ScienceInvestors
Description
Element Biosciences, a developer of technologies to empower science, raised over $277M in Series D funding. The round, which brought the total amount to over $680M, was led by Wellington Management with participation from new and existing investors including Samsung Electronics, Fidelity, and others. The funds will be used to support the commercialization of AVITI™ and bolster the upcoming launch of AVITI24™, an instrument that combines sequencing and cyto-profiling.
Quick answer
Element Biosciences raised $277 Million in a Series D round, dated July 11, 2024. Investors: T. Rowe Price Associates, Venrock, Foresite Capital, Fidelity, Samsung Electronics and Wellington Management. Element Biosciences is based in San Diego, California, United States.
- How much did Element Biosciences raise?
- Element Biosciences raised $277 Million in a Series D round on July 11, 2024.
- Who invested in Element Biosciences?
- T. Rowe Price Associates, Venrock, Foresite Capital, Fidelity, Samsung Electronics and Wellington Management are named as investors in this round.
- What does Element Biosciences do?
- Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets.
- Where is Element Biosciences based and how big is it?
- Element Biosciences is based in San Diego, California, United States.
- Who are the decision-makers at Element Biosciences?
- Fundz holds 1 contact at Element Biosciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Genetics and Life Science around the same time
Companies in the same sectors as Element Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Viome raised $25M on August 19, 2024.
- 4baseCare raised $6M (Series A) on August 12, 2024.
- Bionano Genomics raised $20M on July 8, 2024.
- Matter Bio raised $7M (Seed) on May 29, 2024.
- XO Life raised $7.8M on August 23, 2024.
- Navigator Medicines raised $50M on August 23, 2024.
Who to call at Element Biosciences, and when
A new round usually means Element Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Element Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Element Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Element Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Element Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Element Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.